Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014
Tóm tắt
Tài liệu tham khảo
10.1126/science.1072994
10.1111/j.1749-6632.2000.tb05577.x
10.1001/archneur.56.3.303
10.1111/j.1749-6632.1996.tb32599.x
10.1016/j.jalz.2010.03.007
10.1016/j.nic.2005.09.008
10.1212/WNL.0b013e3181cb3e25
10.1016/j.jalz.2014.11.001
10.1016/S1474-4422(09)70299-6
Weiner MW, 2012, The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception, Alzheimers Dement, 8, S1
10.1016/j.jalz.2013.05.1769
RocheF SvhaererJ GouttardS IstaceA BelaroussiB YuHJ BracoudL PachaiC De CarliC andthe Alzheimer's Neuroimaging Initiative.Accuracy of BMAS hippocampus segmentation using the harmonized hippocampal protocol.Alzheimer's Association International Conference Copenhagen Denmark.2014.
BracoudL MarekK CedarbaumJ SchaererJ MendickS BermanF et al. andthe Alzheimer's Disease Neuroimaging Initiative.Predictive value of baseline hippocampal volumes and brain amyloid burden on atrophy rates for predementia Alzheimer's disease subjects with data from study CN156‐018 and ADNI‐1.Clinical Trials on Alzheimer's Disease (CTAD) conference San Diego CA.2013.
BracoudL CoricV RocheF CedarbaumJ GouttardS LuoF et al.Longitudinal volumetric changes in a predementia AD study of Avagacestat (CN156‐018) as compared to ADNI‐1.Clinical Trials on Alzheimer's Disease (CTAD) conference Philadelphia PA.2013.
RocheF SinghJ SchaererJ BelaroussiB GouttardS IstaceA YuHL FletcherE R BracoudL PachaiC andDecarliCReproducibility of intracranial and hippocampal volume quantification at 1.5T and 3T MRI: application to ADNI I.Alzheimer's Association International Conference Washington DC.2013.
KleinG SampatM StaewenD ScottD LandauS andSuhyJA new look at FDG PET longitudinal analyses in Alzheimer's studies using a Freesurfer native space method.The 12th international conference on Alzheimer's and Parkinson's diseases Nice France.2015.
Klein G, 2015, Comparative assessment of SUVR methods in amyloid cross‐sectional and longitudinal studies
KleinG SampatM StaewenD ScottD andSuhyJHoffman phantom acquisition and analysis methods for qualification of PET centers in Multicenter Neurology Clinical Trials.Clinical Trials on Alzheimer's Disease (CTAD) conference Philadelphia PA.2014.
KleinG LandauS ScottD SharoyanV Koeppe andSuhyJScanner resolution effects on quantitative measurements of Pittsburgh compound B and florbetapir.Alzheimer's Association International Conference Boston MA.2013.
10.1016/j.neurobiolaging.2013.09.039
10.1016/j.neuroimage.2009.09.069
10.1016/j.neuroimage.2010.04.006
10.1016/j.jalz.2013.09.014
10.1016/j.jalz.2013.07.003
10.1056/NEJMoa1304839
10.1212/WNL.0b013e318207b1b9
10.1126/scitranslmed.3002609
10.1056/NEJMp1302513
10.1126/scitranslmed.3007941
10.1016/j.jalz.2010.03.003
10.1002/jmri.21049
10.1016/j.neuroimage.2005.12.013
10.1016/j.jalz.2010.03.004
10.1016/j.neuroimage.2009.05.045
10.1016/j.neuroimage.2007.10.026
10.1118/1.3116776
10.1016/j.neuroimage.2009.11.006
10.1016/j.jalz.2012.06.004
10.1016/j.neuroimage.2010.03.018
10.1016/j.neurobiolaging.2010.04.011
10.1016/j.neuroimage.2011.01.077
10.1016/j.neuroimage.2010.12.067
10.1016/j.media.2013.02.006
10.1001/archneurol.2010.284
10.1016/j.neurobiolaging.2013.02.003
10.1001/jamaneurol.2013.1878
10.1037/a0031063
10.1016/j.jalz.2013.09.003
10.1002/ana.21610
10.1007/s00401-011-0808-0
10.1016/j.ymeth.2012.03.023
10.3233/JAD-132489
Guo LH, 2012, The National Institute on Aging‐Alzheimer's Association research criteria for mild cognitive impairment due to Alzheimer's disease: predicting the outcome, Eur Arch Psychiatry Clin Neurosci, 263, 325
10.1002/ana.23931
10.1212/WNL.0b013e318295d6cf
10.1001/jama.2014.850
10.1016/j.jalz.2010.03.001
10.1016/j.pneurobio.2011.09.005
RammohanKWTransformation of MS care in the 21st century. How NARCRMS will change the way we practice.6th Cooperative Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) and the Americas Committee for Treatment and Research In Multiple Sclerosis (ACTRIMS).2014.
Mormino EC, 2009, Episodic memory loss is related to hippocampal‐mediated beta‐amyloid deposition in elderly subjects, Brain, 132, 1310, 10.1093/brain/awn320
10.1016/S1474-4422(12)70291-0
Mouiha A, 2012, Toward a dynamic biomarker model in Alzheimer's disease, J Alzheimers Dis, 30, 91, 10.3233/JAD-2012-111367
10.1016/j.neuroimage.2012.07.059
10.1001/archneurol.2011.183
Donohue MC, 2014, Estimating long‐term multivariate progression from short‐term data, Alzheimers Dement, 10, S400
Schuff N, 2009, MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers, Brain, 132, 1067, 10.1093/brain/awp007
10.1093/brain/awq277
10.1007/s11682-012-9171-6
10.1016/j.neuroimage.2009.01.004
10.1016/j.neurobiolaging.2010.05.003
10.1016/j.jalz.2010.03.002
10.1016/j.neuroimage.2011.01.049
10.1016/j.neuroimage.2010.02.064
Wu X, 2010, Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment, J Neurosci Methods, 192, 277, 10.1016/j.jneumeth.2010.07.030
10.1016/j.neurobiolaging.2009.07.002
10.1007/s11682-012-9208-x
Morra JH, 2009, Automated mapping of hippocampal atrophy in 1‐year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls, Neuroimage, 45, S3, 10.1016/j.neuroimage.2008.10.043
10.1007/s00330-009-1581-5
10.1002/hbm.20744
10.1016/j.neurobiolaging.2010.07.012
10.1148/radiol.10091402
10.1212/WNL.0b013e318281ccd3
10.1016/j.neurobiolaging.2010.03.015
10.1016/j.neuroimage.2009.02.015
10.1016/j.neurobiolaging.2010.05.001
10.1002/ana.21953
Davatzikos C, 2009, Longitudinal progression of Alzheimer's‐like patterns of atrophy in normal older adults: the SPARE‐AD index, Brain, 132, 2026, 10.1093/brain/awp091
10.1186/2051-5960-1-65
10.1007/s00401-013-1148-z
10.3233/JAD-130458
10.1001/archneurol.2012.1282
10.1371/journal.pone.0028092
10.1371/journal.pone.0034341
10.1097/WAD.0b013e31826d597a
10.1001/jamaneurol.2013.1321
10.1016/j.jalz.2012.11.009
10.1212/WNL.0b013e31826c1b9d
TNir NJahanshad CRJack MWWeiner AWToga PMThompson et al.Small world network measures predict white matter degeneration in patients with early‐stage mild cognitive impairmentProc IEEE Int Symp Biomed Imaging.2012;1405–1408
10.1016/j.nicl.2013.07.006
10.1212/WNL.0b013e3181bc010c
10.1016/j.jalz.2010.08.230
10.1016/j.neuroimage.2013.04.048
10.2967/jnumed.112.109009
10.1016/j.neuroimage.2011.09.069
10.1016/j.neuroimage.2012.04.056
Liu F, 2013, Inter‐modality relationship constrained multi‐task feature selection for AD/MCI classification, Med Image Comput Comput Assist Interv, 16, 308
10.1016/j.neurobiolaging.2013.06.018
10.1371/journal.pone.0055246
10.1371/journal.pone.0047739
10.1002/hbm.21386
10.1016/j.neuroimage.2012.10.086
10.1007/s11682-012-9186-z
Hobart J, 2013, Putting the Alzheimer's cognitive test to the test II: Rasch Measurement Theory, Alzheimers Dement, 9, S10
Hobart J, 2013, Putting the Alzheimer's cognitive test to the test I: traditional psychometric methods, Alzheimers Dement, 9, S4
Llano DA, 2010, Derivation of a new ADAS‐cog composite using tree‐based multivariate analysis: prediction of conversion from mild cognitive impairment to Alzheimer disease, Alzheimer Dis Assoc Disord, 25, 73, 10.1097/WAD.0b013e3181f5b8d8
10.1148/radiol.10100307
10.1016/j.neurobiolaging.2010.04.029
10.1371/journal.pone.0054483
10.1016/j.neuroimage.2008.07.013
10.1016/j.neurobiolaging.2010.04.024
10.1001/archneurol.2011.123
10.3389/fnagi.2013.00011
10.1016/j.jalz.2014.11.001
Rajagopalan P, 2013, TREM2 and neurodegenerative disease, N Engl J Med, 369, 1565
10.1073/pnas.1216206110
10.1038/ng.803
10.1038/ng.801
10.1016/j.neuroimage.2010.01.042
10.1038/mp.2010.123
10.1038/mp.2013.19
10.1007/s11682-013-9262-z
10.1371/journal.pone.0050640
10.1007/s11682-012-9196-x
10.1038/mp.2013.24
10.1038/nature12415
10.1016/j.neuroimage.2010.02.032
10.1001/archneurol.2010.179
10.1001/archgenpsychiatry.2011.155
Randall C, 2013, Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly, Front Biosci, 18, 1150, 10.2741/4170
10.1001/jamaneurol.2014.4829
10.1016/S1474-4422(14)70090-0
Jack CR, 2009, Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease, Brain, 132, 1355, 10.1093/brain/awp062
10.1002/ana.22315
Young AL, 2014, A data‐driven model of biomarker changes in sporadic Alzheimer's disease, Brain, 137, 2564, 10.1093/brain/awu176
10.1371/journal.pone.0047406
10.1007/s11682-012-9177-0
10.1212/WNL.0b013e3181af79e5
10.1212/WNL.0b013e3181af79fb
10.1016/j.neuroimage.2010.06.013
10.1016/j.neuroimage.2011.01.008
10.1016/j.neuroimage.2013.09.015
10.1016/j.neurobiolaging.2010.04.025
Cedarbaum JM, 2013, Rationale for use of the Clinical Dementia Rating Sum of Boxes as a primary outcome measure for Alzheimer's disease clinical trials, Alzheimers Dement, 9, S45
10.1016/j.neurobiolaging.2012.03.006
10.1371/journal.pone.0006501
10.1371/journal.pone.0079771
10.1186/1471-2377-10-90
10.1016/j.neurobiolaging.2010.04.031
10.1371/journal.pone.0070269
10.1016/j.biopsych.2014.05.006
10.1038/ng.2250
10.1038/ng.2237
10.1038/ng.2802
10.1016/j.jalz.2012.04.007
10.1016/j.jalz.2013.03.001
10.1016/j.jalz.2010.03.005
10.1016/j.jalz.2010.06.007
10.1016/j.jalz.2010.03.009
10.1620/tjem.221.87
10.1001/archgenpsychiatry.2010.61
10.1136/jnnp.74.7.857
10.1111/j.1532-5415.2010.02977.x
Khachaturian AS, 2014, Military risk factors for Alzheimer's dementia and neurodegenerative disease, Alzheimer's & dementia: the journal of the Alzheimer's Association, 10, S90
Weiner MW, 2014, Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer's disease in veterans, using the Alzheimer's Disease Neuroimaging Initiative, Alzheimers Dement, 10, S226
Kang JH, 2013, Association of cerebrospinal fluid beta‐amyloid 1‐42, T‐tau, P‐tau181, and alpha‐synuclein levels with clinical features of drug‐naive patients with early Parkinson disease, JAMA Neurol, 70, 1277
10.1038/nrd3822
10.1212/WNL.42.9.1681
10.1001/archneur.1995.00540250089017
10.1002/ana.410410106
10.1212/01.WNL.0000063311.58879.01
10.1212/01.WNL.0000115115.98960.37
Villemagne VL, 2014, In vivo tau imaging: obstacles and progress, Alzheimers Dement, 10, S254
10.1016/j.neuroimage.2008.07.022
10.1186/alzrt240
10.2967/jnumed.112.117341
Okamura N, 2014, Non‐invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F‐THK5105 PET, Brain, 137, 1762, 10.1093/brain/awu064
10.3233/JAD-122059
10.3233/JAD-130098
10.1016/j.neuron.2013.07.037
10.1007/s00259-013-2681-7
10.1016/j.jalz.2013.08.003